HLA association | B | BB | BT | BL | Reaction | Associated phenotype | Population | Reference |
---|---|---|---|---|---|---|---|---|
A*33 | - | - | Susc | - | - | Susc (L. per se) | Korea | 22 |
B*15 | - | - | - | - | Susc | - | - | - |
B*58 | - | Susc | - | - | - | - | - | - |
B*40 | - | - | Prot | - | - | - | - | - |
B*49 | Prot | Prot | Prot | - | - | Prot (L. per se) | Turkey | 35 |
B*53 | - | - | Susc | Susc | - | - | - | - |
C*05 | Prot | Prot | Prot | - | - | Prot (L. per se) | Brazil | 37 |
C*12 | - | Susc | - | - | - | Susc (L. per se) | Brazil | 11 |
C*16 | - | - | Susc | - | - | Prot (L. per se) | Brazil | 11 |
DRB1*03 | - | - | Susc | Prot | - | TT | Different populations | 16,34 |
DRB1*07 | Prot | - | - | Prot | - | Prot (MB) | India | 18 |
DQB1*02 | - | - | - | Prot | - | Prot (MB) | India and Argentina | 18,38 |
DQB1*04 | - | - | - | - | Susc | - | - | - |